Wednesday, June 10, 2026

pharma Β· Breast Cancer Β· Multiple Sclerosis (MS)

HOFFMANN-LA ROCHE

HOFFMANN-LA ROCHE clinical programs β€” 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Mississauga, Ontario L5N 5M8, CA HQ
10 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Mississauga, Ontario L5N 5M8, CA
Employees
10
Programs
286
Drugs
212
Patents
0
Intelligence Β· Clinical Programs

HOFFMANN-LA ROCHE projects

0 ClinicalTrials.gov programs sponsored by HOFFMANN-LA ROCHE.

HOFFMANN-LA ROCHE has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does HOFFMANN-LA ROCHE have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.